Abstracts & Presentations
Research & News
Abstracts & Presentations
Search

You searched for

Showing results in DDL25 – 2014

Clinical pharmacology and physiology of ageing: implications for drug therapy.

Stephen Jackson

Characterisation of Primary Air-Liquid Interface Culture of Nasal Epithelium for Nasal Drug Delivery

Hui Xin Ong, Claire L. Jackson, Janice L. Cole, Elizabeth C. Adam, Peter M. Lackie, Daniela Traini, Paul M. Young, Jane S. Lucas, Joy Conway

In vitro assessment of alveolar macrophage responses to inhaled particulate medicines

V Hutter, D Murnane, K Reitdorf, D Fowler, C Walton, M Bootman

AP301: Development of inhalation medicine from scientific discovery to clinical proof-of-concept for treatment of life-threatening pulmonary oedema

Bernhard Fischer, Susan Tzotzos, Hendrik Fischer, Helmut Pietschmann, Waheed Shabbir, Rosa Lemmens-Gruber, Rudolf Lucas

The Fate of Albumin Nanoparticles in the ‘Black Box’ of the Lung – in vivo Investigations of Albumin Nanoparticle Localisation into Lung Tissue, Broncheoalveolar Lavage Cells and Fluid 48 hours Post-Inhalation

Arcadia Woods, Aateka Patel, Anna Babin Morgan, Yanira Riffo-Vasquez, Kenneth Bruce, Lea Ann Dailey, Ben Forbes

Resveratrol, a Novel Spray Dried Inhalation Powder for the Treatment of COPD and other Inflammatory Lung Diseases

Valentina Trotta, Mehra Haghi , Santo Scalia , Paul Michael Young, Daniela Traini

An in silico Laboratory for Patient-Specific Treatment of Asthma and Chronic Obstructive Pulmonary Disease

L. Nicolaou, T. A. Zaki

Screening and Optimization of Formulation and Process Parameters for the Manufacture of Inhalable Composite Particles by Spray-drying

Cláudia Moura, João Vicente, Maria Palha, Filipe Neves, Ana Aguiar-Ricardo, Eunice Costa

Inhaled nanoparticles develop a complex protein corona: biological importance and implications for sustained release formulations

Abhinav Kumar, Elif Melis Bicer, Paul Pfeffer, Marco Monopoli, Kenneth Dawson, Anders Blomberg, Annelie Behndig, Lea Ann Dailey, Ben Forbes, Ian Mudway

The impact of drug clearance on duration of action of corticosteroids

Amir Hakim, Peter J Barnes, Ian M Adcock, Omar S Usmani

Development of an inhalable pMDI solution formulation of theophylline for COPD

Mary Goud, Mehra Haghi, Bing Zhu, Paul M. Young, Daniela Traini

Are respiratory cell lines proving useful in pharmaceutical development?

Alison B. Lansley, Diane F. Lee, Mike Lethem

Development of a novel laser diffraction method for estimating fine particle fraction of adhesive mixtures

Patrik U Andersson, Marcus Skogevall, Kyrre Thalberg

SPAMS analysis of dry powder formulations containing indacaterol maleate

Anna Susz, Bradley Morrical, David Fergenson

Time-of-Flight Methods for the Measurement of the Aerodynamic Particle Size Distribution of Aerosols from Orally Inhaled Products: Points to Consider

Jolyon Mitchell

Deposition of Aerosols for Dissolution Experiments: How to Combine the One with the Other?

Per Gerde

Evolution or Revolution to Address Patient, Healthcare Professional and Payer Inhalation Device Needs

Richard C. Jenkins

Comparison of Europe‘s TE/BE Guidelines for Orally Inhaled Products with FDA’s Weight of Evidence Approach

Herbert Wachtel, Steve Horhota, Stefan Leiner

Best Practices in Device Design for Orally and Nasally Inhaled Products (OINDP)

Rudi Mueller-Walz, Mark Jackson, Patrick Linnane, Ingo Mett, Jolyon Mitchell, Geoff Newell, Tarlochan Purewal, Christel Schmelzer, Tim Spencer, Markus Tservistas, Gerallt Williams

The rise of mHealth: how technology is being used to support respiratory patients

Georgina Fradley, Matt Bonam, Mark Brincat

The Aerosol Society

Members

Lost Password?

The Aerosol Society recognises the importance of our diverse community and believe that to produce the best quality science we must encourage a proactive and inclusive approach to equality. This can be achieved by developing and retaining a diverse range of talented people to achieve their full potential free from discrimination. We acknowledge our role in engaging with the wider aerosol science community to develop a fair and friendly environment by promoting equality, diversity and inclusion for all, recognising that we come from varying backgrounds and experiences.